INTERNATIONAL PATENT: VIROGIN BIOTECH (SHANGHAI) LTD., VIROGIN BIOTECH CANADA LTD. FILES APPLICATION FOR "ONCOLYTIC VIRAL THERAPY FOR TREATING AND PREVENTING HUMAN PAPILLOMAVIRUS (HPV) -ASSOCIATED MALIGNANCIES"

GENEVA, Nov. 2 -- VIROGIN BIOTECH (SHANGHAI) LTD. (Building 5, No. 28 Xiangle RoadJiading District, Shanghai 201802), VIROGIN BIOTECH CANADA LTD. (150-13511 Commerce Parkway, RichmondBritish Columbia V6V2J8) filed a patent application (PCT/CN2024/089474) for "ONCOLYTIC VIRAL THERAPY FOR TREATING AND PREVENTING HUMAN PAPILLOMAVIRUS (HPV) -ASSOCIATED MALIGNANCIES" on Apr 24, 2024. With publication no. WO/2025/222396, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Kuan (Building 5, No. 28 Xiangle RoadJiading District...